B |
2017-01-17 17:28:49.0 |
Cascadian Therapeutics |
CASC |
BIOTECHNOLOGY VALUE FUND L P |
19.99% |
view |
B |
2016-01-11 18:25:40.0 |
Oncothyreon Inc |
ONTY |
BIOTECHNOLOGY VALUE FUND L P |
19.8% |
view |
B |
2016-01-11 16:14:01.0 |
Oncothyreon Inc |
ONTY |
BIOTECHNOLOGY VALUE FUND L P |
19.8% |
view |
B |
2015-12-21 08:30:46.0 |
Oncothyreon Inc |
ONTY |
BIOTECHNOLOGY VALUE FUND L P |
19.8% |
view |
B |
2015-08-18 17:19:34.0 |
Oncothyreon Inc |
ONTY |
BIOTECHNOLOGY VALUE FUND L P |
15.4% |
view |
S |
2015-05-18 17:29:22.0 |
Oncothyreon Inc |
ONTY |
BIOTECHNOLOGY VALUE FUND L P |
10.3% |
view |
S |
2015-05-18 17:29:08.0 |
Oncothyreon Inc |
ONTY |
BIOTECHNOLOGY VALUE FUND L P |
9.999% |
view |
B |
2015-02-13 20:48:21.0 |
Oncothyreon Inc |
ONTY |
BIOTECHNOLOGY VALUE FUND L P |
15.0% |
view |
B |
2014-02-14 16:44:32.0 |
Oncothyreon Inc |
ONTY |
BIOTECHNOLOGY VALUE FUND L P |
13.0% |
view |
S |
2009-01-27 11:20:19.0 |
NU SKIN ENTERPRISES INC |
NUS |
WELLINGTON MANAGEMENT CO LLP |
10.23% |
view |
B |
2005-02-14 00:00:00.0 |
NU SKIN ENTERPRISES INC |
NUS |
BARCLAYS GLOBAL INVESTORS NA |
5.186% |
view |
S |
2003-02-12 00:00:00.0 |
NU SKIN ENTERPRISES INC |
NUS |
WELLINGTON MANAGEMENT CO LLP |
10.83% |
view |